Sheng Yang
Impact in
- Infectious Diseases top 0.2%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Neurology top 0.5%
- Long-Term Effects of COVID-19
- Neuroinflammation and Neurodegeneration Mechanisms
Papers in
-
- Advanced biosensing and bioanalysis techniques 7
- RNA modifications and cancer 6
- Circular RNAs in diseases 6
- Oncology 23
- Co-authors
- Luo‐Qi Zhou (19 shared papers)Dai‐Shi Tian (19 shared papers)Chuan Qin (17 shared papers)Ziwei Hu (4 shared papers)Shuoqi Zhang (3 shared papers)Ke Shang (10 shared papers)Cuihong Xie (2 shared papers)Ke Ma (2 shared papers)
- Journals
- Current Pharmaceutical Biotechnology (4 papers)Scientific Reports (2 papers)Frontiers in Plant Science (2 papers)Medicine (2 papers)Analytical Chemistry (2 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Sheng Yang
157 papers receiving 7.7k citations
Sheng Yang's Hit Papers
Peers
Comparison fields: 5 of 159
- Infectious Diseases 2.9k
- Neurology 1.5k
- Neurology 776
- Biological Psychiatry 90
- Immunology 791
Countries citing papers authored by Sheng Yang
This map shows the geographic impact of Sheng Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheng Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheng Yang more than expected).
Fields of papers citing papers by Sheng Yang
This network shows the impact of papers produced by Sheng Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheng Yang. The network helps show where Sheng Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Sheng Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 175 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China Hit paper breakdown → | 2020 | 3459 |
| 2 | Dysregulation of Immune Response in Patients with COVID-19 in Wuhan, China Hit paper breakdown → | 2020 | 618 |
| 3 | Signaling pathways involved in ischemic stroke: molecular mechanisms and therapeutic interventions Hit paper breakdown → | 2022 | 577 |
| 4 | Dual Functions of Microglia in Ischemic Stroke Hit paper breakdown → | 2019 | 435 |
| 5 | 2018 | 199 | |
| 6 | 2021 | 168 | |
| 7 | 2018 | 162 | |
| 8 | Modification, 3D printing process and application of sodium alginate based hydrogels in soft tissue engineering: A review Hit paper breakdown → | 2023 | 141 |
| 9 | 2018 | 120 | |
| 10 | 2020 | 97 | |
| 11 | 2012 | 87 | |
| 12 | 1995 | 81 | |
| 13 | 2016 | 58 | |
| 14 | 2019 | 57 | |
| 15 | 2023 | 56 | |
| 16 | 2020 | 55 | |
| 17 | 2012 | 45 | |
| 18 | 1993 | 43 | |
| 19 | 2018 | 43 | |
| 20 | 2015 | 36 |
About Sheng Yang
Sheng Yang is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Surgery and Immunology, having authored 175 papers that have together received 7.8k indexed citations. Recurring topics across this work include Neuroinflammation and Neurodegeneration Mechanisms (14 papers), MicroRNA in disease regulation (10 papers), Gastric Cancer Management and Outcomes (8 papers), Advanced biosensing and bioanalysis techniques (7 papers), Lymphoma Diagnosis and Treatment (7 papers), RNA modifications and cancer (6 papers), Circular RNAs in diseases (6 papers) and Cancer-related molecular mechanisms research (5 papers). The work is most often cited by research in Infectious Diseases (2.9k citations), Neurology (1.5k citations), Neurology (776 citations), Biological Psychiatry (90 citations) and Immunology (791 citations). Sheng Yang has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Luo‐Qi Zhou, Dai‐Shi Tian, Chuan Qin, Ziwei Hu, Shuoqi Zhang, Ke Shang, Cuihong Xie, Ke Ma, Wei Wang and Tao Yu. Their work appears in journals such as Current Pharmaceutical Biotechnology, Scientific Reports, Frontiers in Plant Science, Medicine and Analytical Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.